Recruiting Pulmonary Fibrosis Studies in Oklahoma City
About Pulmonary Fibrosis Clinical Trials in Oklahoma City
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 1 pulmonary fibrosis clinical trials recruiting participants in Oklahoma City, OKLAHOMA. These studies are seeking a combined 60 participants. Research is being sponsored by InSilico Medicine Hong Kong Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Oklahoma City — FAQ
Are there pulmonary fibrosis clinical trials in Oklahoma City?
Yes, there are 1 pulmonary fibrosis clinical trials currently recruiting in Oklahoma City, OKLAHOMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Oklahoma City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.
Are clinical trials in Oklahoma City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 1 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov